Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 10, Pages 2286
Publisher
MDPI AG
Online
2020-10-16
DOI
10.3390/cells9102286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of AIM2 inflammasome activation alleviates GSDMD-induced pyroptosis in early brain injury after subarachnoid haemorrhage
- (2020) Bin Yuan et al. Cell Death & Disease
- Pyroptotic cell death in the R6/2 mouse model of Huntington’s disease: new insight on the inflammasome
- (2020) Emanuela Paldino et al. Cell Death Discovery
- Inflammasomes in neuroinflammatory and neurodegenerative diseases
- (2019) Sofie Voet et al. EMBO Molecular Medicine
- PARP inhibition by olaparib alleviates chronic asthma‐associated remodeling features via modulating inflammasome signaling in mice
- (2019) Gurupreet S. Sethi et al. IUBMB LIFE
- NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
- (2017) Jun Yin et al. MOLECULAR NEUROBIOLOGY
- Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia
- (2016) Fei Teng et al. NEUROCHEMICAL RESEARCH
- Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity
- (2016) Jin-Chong Xu et al. Science Translational Medicine
- Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca2+ Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
- (2015) Elisabetta Gerace et al. CNS & Neurological Disorders-Drug Targets
- PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
- (2015) Antonella Cardinale et al. PLoS One
- Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited
- (2014) Barbara Lupo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Beyond DNA repair, the immunological role of PARP-1 and its siblings
- (2013) Maria Manuela Rosado et al. IMMUNOLOGY
- Therapeutic approaches to preventing cell death in Huntington disease
- (2012) Anna Kaplan et al. PROGRESS IN NEUROBIOLOGY
- Caspase-1-induced pyroptotic cell death
- (2011) Edward A. Miao et al. IMMUNOLOGICAL REVIEWS
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Poly(ADP-Ribose) Metabolism in Brain and Its Role in Ischemia Pathology
- (2010) Robert Piotr Strosznajder et al. MOLECULAR NEUROBIOLOGY
- Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos
- (2009) Yingfei Wang et al. EXPERIMENTAL NEUROLOGY
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started